Web Analytics

3 Latest Announced Rounds

  • $3,500,000
    Seed

    1 Investors

    Technology, Information and Internet
    Dec 20th, 2024
  • $5,619,170
    Series B

    1 Investors

    Research Services
    Dec 20th, 2024
  • $8,000,000
    Unknown

    5 Investors

    Computer & Network Security
    Dec 20th, 2024
$671.88M Raised in 44 Funding Rounds in the past 7 Days - View All

Funding Round Profile

HeartFlow, Inc

start up
United States - Mountain View, California
  • 07/04/2023
  • Series F
  • $215,000,000

HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease--the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide.

Cleared for use in the United States, Canada, Europe and Japan and with offices in Redwood City, Austin, London and Japan, HeartFlow’s footprint is growing rapidly. HeartFlow has received more than $240 million dollars in funding in a recent Series E financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics.

We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care.

For more information, visit www.heartflow.com.


Related People

John FarquharFounder

John Farquhar United States - San Francisco Bay Area

Experienced healthcare executive focused on building high performing teams and businesses. Interested in helping innovative healthcare companies grow and patients gain access to better therapies and outcomes.

Proven global experience in P&L management, sales and marketing leadership, new product launches, turnarounds and market development across multiple geographies (Asia Pacific and Americas) and segments (Cardiovascular, Diabetes and Consumer Health.)

Specialties: General Management, P&L Management, Strategy, Business Development, Sales Leadership, Marketing, New Product Development, New Product Launches, SAAS, AI, Machine Learning, Operations, Market Development, Market Access, Asia Pacific, Medical Devices, Diabetes, Cardiology and Vascular Surgery